Coastlands reports 9.99% stake in Minerva Neurosciences

Minerva Neurosciences discloses a 9.99% beneficial ownership position by Coastlands entities.

Rhea-AI Filing Summary

Minerva Neurosciences discloses a 9.99% beneficial ownership position by Coastlands entities. The reporting persons state ownership of 4,563,031 shares, based on 43,274,398 shares outstanding as of December 23, 2025. The total consists of 2,159,245 shares held and 2,403,786 shares issuable upon conversion of Series A Convertible Preferred Stock and exercise of related warrants, with a stated beneficial ownership limitation of 9.99%.

The filing clarifies shared voting and dispositive power of 4,563,031 shares across Coastlands Capital LP, related entities, and Matthew D. Perry, and disclaims group membership and additional beneficial ownership beyond the 9.99% limitation.

Insights

Institutional Ownership Analyst

Coastlands holds a disclosed 9.99% position in Minerva, partly via convertible securities.

Coastlands Capital and affiliated entities report beneficial ownership of 4,563,031 shares, including 2,403,786 shares issuable on conversion/exercise. The filing anchors this percentage to an explicit outstanding share count: December 23, 2025.

Holdings are reported with shared voting and dispositive power. The disclosed 9.99% beneficial ownership limitation constrains inclusion of any additional convertible/warrant amounts above that cap; subsequent filings would reflect any change in the capped calculation.

Governance Counsel

The disclosure emphasizes control-person relationships and standard disclaimers of group status.

The filing identifies the reporting persons and notes that Mr. Matthew D. Perry is the control person for the Coastlands entities and that the parties "disclaim membership in a group." It also states that the Partnership holds shares for investors and can direct dividends or proceeds.

Signatures include the Chief Operating Officer and the reporting person; the filing includes an agreement about the joint filing. Any material change in percent ownership or voting power would require an updated filing.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does Coastlands hold in Minerva Neurosciences (NERV)?

Coastlands and affiliated filers report beneficial ownership of 4,563,031 shares, equal to 9.99% of the class. This percentage uses an outstanding share base of 43,274,398 shares as of December 23, 2025 and reflects a 9.99% ownership cap.

How is the 4,563,031 share count composed?

The total comprises 2,159,245 shares held plus 2,403,786 shares issuable upon conversion of Series A Preferred and exercise of related warrants. The filing explicitly ties the issuable shares to convertible preferred/warrant instruments.

Who is the reporting person for this Schedule 13G filing?

The filing lists Coastlands Capital LP, associated Coastlands entities, and Matthew D. Perry as reporting persons. It states Mr. Perry is the control person of the listed Coastlands entities and includes standard disclaimers regarding group membership.

Does the filing indicate who holds voting or dispositive power?

The reporting persons disclose shared voting power and shared dispositive power over 4,563,031 shares; each reports zero sole voting or sole dispositive power. Details appear in Item 4 of the filing.

Are all convertible and warrant shares fully counted in the ownership percentage?

The filing counts 2,403,786 issuable shares but states the 9.99% beneficial ownership limitation is applied; shares in excess of that limit are excluded from the calculation. The outstanding share base used is 43,274,398 as of December 23, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/20/2026 - 04:01 PM EST Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Minerva Neurosciences, Inc.

(Name of Issuer)

Common Stock, par value $0.0001 per share

(Title of Class of Securities)

603380205

(CUSIP Number)

02/13/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 603380205

1

Names of Reporting Persons

Coastlands Capital LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,563,031.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,563,031.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,563,031.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

IA, PN

Comment for Type of Reporting Person: Consists of 2,159,245 shares of Common Stock held by Coastlands Capital LP and 2,403,786 shares of Common Stock issuable upon the conversion of shares of Series A Convertible Preferred Stock, par value $0.0001 per share ("Series A Preferred Stock"), and the exercise of warrants to acquire shares of Series A Preferred Stock held by Coastlands Capital LP. The calculation of the beneficial ownership of the Reporting Persons is based on (A) 43,274,398 shares outstanding as December 23, 2025, as disclosed in the prospectus filed by the Issuer pursuant to Rule 424(b)(3) on January 6, 2026, and (B) 2,403,786 shares of Common Stock issuable upon the conversion of shares of Series A Preferred Stock and the exercise of warrants to acquire shares of Series A Preferred Stock held by the Reporting Persons, which reflects the beneficial ownership limitation of 9.99%. Excludes shares of Series A Preferred Stock and warrants to acquire shares of Series A Preferred Stock held by the Reporting Persons in excess of such beneficial ownership limitation.

SCHEDULE 13G

CUSIP No. 603380205

1

Names of Reporting Persons

Coastlands Capital Partners LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,563,031.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,563,031.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,563,031.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person: Consists of 2,159,245 shares of Common Stock held by Coastlands Capital LP and 2,403,786 shares of Common Stock issuable upon the conversion of shares of Series A Preferred Stock and the exercise of warrants to acquire shares of Series A Preferred Stock held by Coastlands Capital LP. The calculation of the beneficial ownership of the Reporting Persons is based on (A) 43,274,398 shares outstanding as December 23, 2025, as disclosed in the prospectus filed by the Issuer pursuant to Rule 424(b)(3) on January 6, 2026, and (B) 2,403,786 shares of Common Stock issuable upon the conversion of shares of Series A Preferred Stock and the exercise of warrants to acquire shares of Series A Preferred Stock held by the Reporting Persons, which reflects the beneficial ownership limitation of 9.99%. Excludes shares of Series A Preferred Stock and warrants to acquire shares of Series A Preferred Stock held by the Reporting Persons in excess of such beneficial ownership limitation.

SCHEDULE 13G

CUSIP No. 603380205

1

Names of Reporting Persons

Coastlands Capital GP LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,563,031.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,563,031.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,563,031.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: Consists of 2,159,245 shares of Common Stock held by Coastlands Capital LP and 2,403,786 shares of Common Stock issuable upon the conversion of shares of Series A Preferred Stock and the exercise of warrants to acquire shares of Series A Preferred Stock held by Coastlands Capital LP. The calculation of the beneficial ownership of the Reporting Persons is based on (A) 43,274,398 shares outstanding as December 23, 2025, as disclosed in the prospectus filed by the Issuer pursuant to Rule 424(b)(3) on January 6, 2026, and (B) 2,403,786 shares of Common Stock issuable upon the conversion of shares of Series A Preferred Stock and the exercise of warrants to acquire shares of Series A Preferred Stock held by the Reporting Persons, which reflects the beneficial ownership limitation of 9.99%. Excludes shares of Series A Preferred Stock and warrants to acquire shares of Series A Preferred Stock held by the Reporting Persons in excess of such beneficial ownership limitation.

SCHEDULE 13G

CUSIP No. 603380205

1

Names of Reporting Persons

Coastlands Capital LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,563,031.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,563,031.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,563,031.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

HC, OO

Comment for Type of Reporting Person: Consists of 2,159,245 shares of Common Stock held by Coastlands Capital LP and 2,403,786 shares of Common Stock issuable upon the conversion of shares of Series A Preferred Stock and the exercise of warrants to acquire shares of Series A Preferred Stock held by Coastlands Capital LP. The calculation of the beneficial ownership of the Reporting Persons is based on (A) 43,274,398 shares outstanding as December 23, 2025, as disclosed in the prospectus filed by the Issuer pursuant to Rule 424(b)(3) on January 6, 2026, and (B) 2,403,786 shares of Common Stock issuable upon the conversion of shares of Series A Preferred Stock and the exercise of warrants to acquire shares of Series A Preferred Stock held by the Reporting Persons, which reflects the beneficial ownership limitation of 9.99%. Excludes shares of Series A Preferred Stock and warrants to acquire shares of Series A Preferred Stock held by the Reporting Persons in excess of such beneficial ownership limitation.

SCHEDULE 13G

CUSIP No. 603380205

1

Names of Reporting Persons

Matthew D. Perry

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,563,031.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,563,031.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,563,031.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

HC, IN

Comment for Type of Reporting Person: Consists of 2,159,245 shares of Common Stock held by Coastlands Capital LP and 2,403,786 shares of Common Stock issuable upon the conversion of shares of Series A Preferred Stock and the exercise of warrants to acquire shares of Series A Preferred Stock held by Coastlands Capital LP. The calculation of the beneficial ownership of the Reporting Persons is based on (A) 43,274,398 shares outstanding as December 23, 2025, as disclosed in the prospectus filed by the Issuer pursuant to Rule 424(b)(3) on January 6, 2026, and (B) 2,403,786 shares of Common Stock issuable upon the conversion of shares of Series A Preferred Stock and the exercise of warrants to acquire shares of Series A Preferred Stock held by the Reporting Persons, which reflects the beneficial ownership limitation of 9.99%. Excludes shares of Series A Preferred Stock and warrants to acquire shares of Series A Preferred Stock held by the Reporting Persons in excess of such beneficial ownership limitation.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Minerva Neurosciences, Inc.
(b)	Address of issuer's principal executive offices: 1500 District Avenue, Burlington, MA 01803
Item 2.
(a)	Name of person filing: Coastlands Capital LP, a Delaware limited partnership ("Coastlands") Coastlands Capital Partners LP, a Delaware limited partnership (the "Partnership") Coastlands Capital GP LLC, a Delaware limited liability company (the "General Partner") Coastlands Capital LLC, a Delaware limited liability company ("Coastlands GP") Matthew D. Perry Coastlands and the General Partner are the investment adviser and general partner, respectively, of the Partnership. Coastlands GP is the general partner of Coastlands. Mr. Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Schedule 13G jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of Common Stock except to the extent of that person's pecuniary interest therein. In addition, the filing of this Schedule 13G on behalf of the Partnership should not be construed as an admission that it is, and it disclaims that it is, a beneficial owner, as defined in Rule 13d-3 under the Act, of any Common Stock covered by this Schedule 13G.
(b)	Address or principal business office or, if none, residence: 601 California Street, Suite 1210, San Francisco, CA 94108
(c)	Citizenship: See Item 4 of the cover sheet for each reporting person.
(d)	Title of class of securities: Common Stock, par value $0.0001 per share
(e)	CUSIP No.: 603380205
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Coastlands: 4,563,031 Partnership: 4,563,031 General Partner: 4,563,031 Coastlands GP: 4,563,031 Matthew D. Perry: 4,563,031
(b)	Percent of class: Coastlands: 9.99% Partnership: 9.99% General Partner: 9.99% Coastlands GP: 9.99% Matthew D. Perry: 9.99%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Coastlands: 0 Partnership: 0 General Partner: 0 Coastlands GP: 0 Matthew D. Perry: 0
	(ii) Shared power to vote or to direct the vote: Coastlands: 4,563,031 Partnership: 4,563,031 General Partner: 4,563,031 Coastlands GP: 4,563,031 Matthew D. Perry: 4,563,031
	(iii) Sole power to dispose or to direct the disposition of: Coastlands: 0 Partnership: 0 General Partner: 0 Coastlands GP: 0 Matthew D. Perry: 0
	(iv) Shared power to dispose or to direct the disposition of: Coastlands: 4,563,031 Partnership: 4,563,031 General Partner: 4,563,031 Coastlands GP: 4,563,031 Matthew D. Perry: 4,563,031
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. The Partnership holds the shares of Common Stock, including shares of Common Stock issuable upon conversion of shares of Series A Preferred Stock, including shares of Series A Preferred Stock issuable upon exercise of warrants to acquire shares of Series A Preferred Stock, for the benefit of its investors and has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, shares of Common Stock, including shares of Common Stock issuable upon conversion of shares of Series A Preferred Stock, including shares of Series A Preferred Stock issuable upon exercise of warrants to acquire shares of Series A Preferred Stock.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Coastlands Capital LP

Signature:	/s/ Mark Shamia
Name/Title:	Chief Operating Officer of the General Partner, Coastlands Capital LLC
Date:	02/20/2026

Coastlands Capital Partners LP

Signature:	/s/ Mark Shamia
Name/Title:	Chief Operating Officer of the General Partner, Coastlands Capital GP LLC
Date:	02/20/2026

Coastlands Capital GP LLC

Signature:	/s/ Mark Shamia
Name/Title:	Chief Operating Officer
Date:	02/20/2026

Coastlands Capital LLC

Signature:	/s/ Mark Shamia
Name/Title:	Chief Operating Officer
Date:	02/20/2026

Matthew D. Perry

Signature:	/s/ Matthew D. Perry
Name/Title:	Reporting Person
Date:	02/20/2026

Comments accompanying signature: Exhibit 99.1 - Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G